Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735 [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
The company's completion of subject enrollment for the Phase 2 clinical trial of VK2735, targeting weight loss, and promising results from earlier phases have bolstered investor confidence, contributing to the stock's positive movement. The recent announcements about both oral and subcutaneous formulations underscore the potential of VK2735. With the broader market remaining flat during this period, these developments likely provided additional momentum to Viking's notable stock performance. Every company has risks, and we've spotted 4 risks for Viking Therapeutics (of which 2 are concerning!) you should know about. AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Over a three-year period, Viking Therapeutics' stock has delivered a total return exceeding 500%, showcasing its robust performance for long-term investors. Th
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Why Viking Therapeutics Stock Bumped 3% Higher Today [Yahoo! Finance]Yahoo! Finance
- 3 Monster Stocks in the Making [Yahoo! Finance]Yahoo! Finance
- Why Viking Therapeutics Stock Was Victorious This Week [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 [Yahoo! Finance]Yahoo! Finance
- Where Will Viking Therapeutics Be in 3 Years? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 4/23/25 - Miss
VKTX
Sec Filings
- 5/12/25 - Form SCHEDULE
- 4/24/25 - Form 10-Q
- 4/23/25 - Form DEFA14A
- VKTX's page on the SEC website